In 2024, AI revolutionized drug development in the broader pharmaceutical landscape. Companies increasingly integrated AI to accelerate research, optimize clinical trials, and personalize patient care. This trend underscores the growing importance of AI-driven solutions in enhancing patient treatment efficiencies and outcomes.
OM1 is at the forefront of this transformation – our award-winning, patented AI-powered digital phenotyping technology provides deeper patient insights and comprehensive evidence generation, resulting in a more complete understanding of the patient journey. We remain committed to empower our clients with the cutting-edge tools and insights needed for success in today’s rapidly evolving industry.
Read this eBook for OM1’s top insights from 2024!
